These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 27835939

  • 21. Prolonged Scar-in-a-Jar: an in vitro screening tool for anti-fibrotic therapies using biomarkers of extracellular matrix synthesis.
    Rønnow SR, Dabbagh RQ, Genovese F, Nanthakumar CB, Barrett VJ, Good RB, Brockbank S, Cruwys S, Jessen H, Sorensen GL, Karsdal MA, Leeming DJ, Sand JMB.
    Respir Res; 2020 May 07; 21(1):108. PubMed ID: 32381012
    [Abstract] [Full Text] [Related]

  • 22. Vitamin D attenuates myofibroblast differentiation and extracellular matrix accumulation in nasal polyp-derived fibroblasts through smad2/3 signaling pathway.
    Lee SA, Yang HW, Um JY, Shin JM, Park IH, Lee HM.
    Sci Rep; 2017 Aug 04; 7(1):7299. PubMed ID: 28779150
    [Abstract] [Full Text] [Related]

  • 23. Nintedanib inhibits TGF-β-induced myofibroblast transdifferentiation in human Tenon's fibroblasts.
    Lin X, Wen J, Liu R, Gao W, Qu B, Yu M.
    Mol Vis; 2018 Aug 04; 24():789-800. PubMed ID: 30636861
    [Abstract] [Full Text] [Related]

  • 24. Dupuytren's Disease Is Mediated by Insufficient TGF-β1 Release and Degradation.
    Oezel L, Wohltmann M, Gondorf N, Wille J, Güven I, Windolf J, Thelen S, Jaekel C, Grotheer V.
    Int J Mol Sci; 2023 Oct 11; 24(20):. PubMed ID: 37894778
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
    Li Z, Liu X, Wang B, Nie Y, Wen J, Wang Q, Gu C.
    Nephrology (Carlton); 2017 Aug 11; 22(8):589-597. PubMed ID: 27245114
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pirfenidone inhibits TGF-β1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells.
    Hisatomi K, Mukae H, Sakamoto N, Ishimatsu Y, Kakugawa T, Hara S, Fujita H, Nakamichi S, Oku H, Urata Y, Kubota H, Nagata K, Kohno S.
    BMC Pulm Med; 2012 Jun 13; 12():24. PubMed ID: 22694981
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation.
    Jemec B, Linge C, Grobbelaar AO, Smith PJ, Sanders R, McGrouther DA.
    Chir Main; 2000 Feb 13; 19(1):15-22. PubMed ID: 10777424
    [Abstract] [Full Text] [Related]

  • 38. Possible involvement of pirfenidone metabolites in the antifibrotic action of a therapy for idiopathic pulmonary fibrosis.
    Togami K, Kanehira Y, Tada H.
    Biol Pharm Bull; 2013 Feb 13; 36(10):1525-7. PubMed ID: 24088250
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.